Evaxion Biotech A/S (NASDAQ:EVAX) Upgraded by Zacks Investment Research to Hold

Evaxion Biotech A/S} stock has undergone multiple analysts rating changes in the recent past.  Evaxion Biotech A/S Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Evaxion Biotech A/S (NASDAQ:EVAX) Upgraded by Zacks Investment Research to Hold